Immunization Action Month, October 1974

PEDIATRICS ◽  
1974 ◽  
Vol 54 (3) ◽  
pp. 380-380
Author(s):  
Samuel L. Katz

The Executive Board of the American Academy of Pediatrics, in a recent session, unanimously approved a resolution supporting Immunization Action Month, October 1974, in order to stimulate a more widespread immunization of American children against poliomyelitis, diphtheria, rubella, mumps, pertussis and tetanus. It is completely appropriate, therefore, that the Academy take an active role in a nationwide effort to make October 1974 a month for emphasis and promotion of childhood immunization. Joining with the Academy in this effort are the American Medical Association, American Academy of Family Physicians, National Medical Association, American Osteopathic Association, American Nurses Association, American League of Nursing, five major service organizations and five manufacturers of biologics. The entire campaign is initiated and coordinated by the Center for Disease Control. The aims of this national effort are twofold: (1) "to motivate parents to check the immunization status of their children with their family doctor"; and (2) "to create receptivity on the part of the physician to these parental inquiries and encourage him and his office nurse to conduct an ongoing office audit of the immunization record of every child he sees." A third goal should be to make every effort to reach those indigent and other disadvantaged groups who do not receive consistent health care. Why is such a campaign necessary? The striking reductions in the numbers of reported cases of diphtheria, tetanus, pentussis, poliomyelitis, and measles attest to the remarkable efficacy of the vaccines in the prevention of these diseases. Disquieting information has arisen from two sources: (1) the surveillance reports of infectious diseases; and (2) the surveys of the immunization levels of preschoolers and those children at the time of school entry.1

JAMA ◽  
1995 ◽  
Vol 274 (12) ◽  
pp. 929 ◽  
Author(s):  
Charles Marwick

PEDIATRICS ◽  
1996 ◽  
Vol 97 (1) ◽  
pp. 143-143
Author(s):  

The Recommended Childhood Immunization Schedule for 1995 was developed by the Committee on Infectious Diseases (COID) of the American Academy of Pediatrics in collaboration with the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) and the American Academy of Family Physicians (AAFP).1 Since the January 1995 publication, the AAP, ACIP, and AAFP have agreed on the following revisions: 1. The revised schedule is dated January-June 1996 and will be reprinted in July 1996 with any indicated changes. Incorporating dates in the chart will assure health care providers that they are using the most current schedule. 2. A column has been added to indicate that the second dose of hepatitis B vaccine can be administered at 1 month of age, provided that at least 1 month has elapsed since the first dose was given. Also, the doses of vaccine are provided in micrograms by individual product instead of volume, as several different concentrations of recombivax-HB (Merck, Sharp and Dohme) vaccine are available. 3. A bar has been added at 11-12 years of age to indicate that adolescents who have not previously received three doses of hepatitis B vaccine should initiate or complete the three-dose series. 4. Varicella zoster virus vaccine (Var) has been added to the schedule. In addition to the previously issued Academy recommendations, answers to commonly asked questions are addressed in a recent AAP News article.2,3 5. Information on inactivated poliomyelitis vaccine (IPV) has been added to reflect the Academy's current policy.


2021 ◽  
Vol 37 (2) ◽  
pp. 133-144
Author(s):  
Ricardo Garcia Silva ◽  
◽  
Sofia Piarali Remtula ◽  
Tiago Castelar Gonçalves ◽  
◽  
...  

Objetivo: Avaliar a evidência existente relativa à eficácia de canabinoides no tratamento da dor crónica. Fontes de dados: MEDLINE/PubMed, Cochrane Library, TRIP Database, National Guideline Clearing House, Canadian Medical Association Practice Guidelines. Métodos de revisão: Utilizando os termos MeSH cannabis e chronic pain fez-se, em agosto de 2019, uma pesquisa de meta-análises (MA), revisões sistemáticas (RS), estudos observacionais (EO), ensaios clínicos (EC) e guidelines, publicados em português e inglês, sem limite temporal. Incluíram-se estudos realizados em adultos com dor crónica, independentemente da causa, submetidos a terapêutica com canabinoides, excluindo-se aqueles com intervenção em dor aguda. Utilizou-se a escala Strength of Recommendation Taxonomy, da American Academy of Family Physicians, para atribuir níveis de evidência (NE) e força de recomendação (FR). Resultados: Dos 244 artigos encontrados, 16 cumpriram os critérios de inclusão: nove RS, quatro EC duplo-cegos aleatorizados e controlados com placebo, dois estudos retrospetivos de série de casos e um estudo prospetivo de série de casos. Todos os estudos selecionados abordavam dor crónica, mas de etiologia diversa (oncológica, neuropática, reumatológica, visceral). Os resultados entre os estudos não foram consistentes. Parece haver algum benefício na dor neuropática e na dor oncológica, embora haja consenso pelas revisões de que serão necessários estudos de maior dimensão e duração para que a utilização de canabinoides tenha evidência robusta. Podem verificar-se efeitos adversos gastrointestinais e nas funções cognitiva e motora, sobretudo com as preparações contendo maior dosagem de tetrahidrocanabinol. Não há evidência para utilização em dor de origem reumatológica ou visceral. Não se atribuiu NE 1 a qualquer estudo. Conclusões: A utilização de canabinoides, embora promissora e com eventual benefício identificado em pequenos estudos para alguns tipos de dor crónica (sobretudo a neuropática), tem evidência limitada (FR B) e requer a realização de ensaios de maior qualidade e dimensão. Devem ser considerados a eficácia e os possíveis efeitos secundários a longo prazo em estudos de maior duração, algo que poderá ser alcançado com a crescente utilização dos fármacos na prática clínica. Com base na evidência disponível, os canabinoides poderão ser uma solução de última linha em casos de dor refratária neuropática e oncológica.


2016 ◽  
pp. 18-19
Author(s):  
Larysa Matіukha

Resolution of the scientific conference of the Ukrainian Association of Family Medicine and the National Medical Academy of Postgraduate Education named after P. L. Shupyk «Health in the hands of Ukrainian family doctor» 08-09.12.2016.


PEDIATRICS ◽  
1975 ◽  
Vol 56 (4) ◽  
pp. 502-503
Author(s):  
Samuel l. Katz

For the third consecutive year October has been designated as Immunization Action Month (IAM). This is the effort of a coalition of governmental, professional, and private groups to highlight the need for continued attention to the immunization programs of all American children, particularly the pre-school group. The American Academy of Pediatrics since the inception of IAM has been among the leaders in its activities. Once again this year, the members of the Academy are urged to participate actively on the local scene in generating information about the goals of IAM and in implementing them. The justification for continued efforts of this sort must be found in the data on the utilization of vaccines and on the reported cases of those diseases which can be prevented.


Sign in / Sign up

Export Citation Format

Share Document